Immunovia AB (publ) (LON:0G8X)
London · Delayed Price · Currency is GBP · Price in SEK 0.2000
-0.0090 (-4.31%)
At close: Feb 3, 2026
Immunovia AB Market Cap
Immunovia AB has a market cap or net worth of 9.95 million as of February 12, 2026. Its market cap has increased by 12.65% in one year.
Market Cap
9.95M
Enterprise Value
9.44M
Revenue
62.06K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since December 1, 2015, Immunovia AB's market cap has decreased from 32.41M to 9.95M, a decrease of -69.30%. That is a compound annual growth rate of -10.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 9.95M | -19.31% |
| Dec 30, 2025 | 12.33M | 83.92% |
| Dec 30, 2024 | 6.70M | 7.32% |
| Dec 29, 2023 | 6.25M | -86.82% |
| Dec 30, 2022 | 47.39M | -65.91% |
| Dec 30, 2021 | 139.03M | -42.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| CelLBxHealth | 11.93M |
| Oxford BioDynamics | 11.80M |
| genedrive | 11.33M |
| Verici Dx | 10.22M |